Last reviewed · How we verify
Levodopa Carbidopa immediate release tablets — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Levodopa Carbidopa immediate release tablets (Levodopa Carbidopa immediate release tablets) — Desitin Arzneimittel GmbH.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Levodopa Carbidopa immediate release tablets TARGET | Levodopa Carbidopa immediate release tablets | Desitin Arzneimittel GmbH | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Levodopa Carbidopa immediate release tablets CI watch — RSS
- Levodopa Carbidopa immediate release tablets CI watch — Atom
- Levodopa Carbidopa immediate release tablets CI watch — JSON
- Levodopa Carbidopa immediate release tablets alone — RSS
Cite this brief
Drug Landscape (2026). Levodopa Carbidopa immediate release tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/levodopa-carbidopa-immediate-release-tablets. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing